Adenovirus News and Research

RSS
Adenoviruses most commonly cause respiratory illness; however, depending on the infecting serotype, they may also cause various other illnesses, such as gastroenteritis, conjunctivitis, cystitis, and rash illness. Symptoms of respiratory illness caused by adenovirus infection range from the common cold syndrome to pneumonia, croup, and bronchitis. Patients with compromised immune systems are especially susceptible to severe complications of adenovirus infection. Acute respiratory disease (ARD), first recognized among military recruits during World War II, can be caused by adenovirus infections during conditions of crowding and stress.
COVID-19 vaccine candidate protects animals against SARS-CoV-2

COVID-19 vaccine candidate protects animals against SARS-CoV-2

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

UC San Diego participates in second, massive clinical trial of COVID-19 vaccine

Italy starts human trials of potential COVID-19 vaccine

Italy starts human trials of potential COVID-19 vaccine

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

Single dose nasal vaccine against SARS-CoV-2 shows promise in animal studies

New cancer vaccine is predicted to be more effective in human trials

New cancer vaccine is predicted to be more effective in human trials

Nasal vaccine effective in preventing COVID-19 infection in mice

Nasal vaccine effective in preventing COVID-19 infection in mice

Single-dose adenovirus-vectored vaccine protects mice against SARS-CoV-2

Single-dose adenovirus-vectored vaccine protects mice against SARS-CoV-2

CDC warns acute flaccid myelitis is poised for a comeback in kids this fall

CDC warns acute flaccid myelitis is poised for a comeback in kids this fall

Stabilized prefusion spike vaccine candidate induces powerful immune response

Stabilized prefusion spike vaccine candidate induces powerful immune response

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Novel vaccine candidate robustly protects non-human primates against SARS-CoV-2

Scientists want to know more about using UV light to fight COVID-19 spread

Scientists want to know more about using UV light to fight COVID-19 spread

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

China's Ad5 vectored COVID-19 vaccine safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Oxford University and AstraZeneca vaccine against SARS-CoV-2 safe and induces immune response

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Oxford University and AstraZeneca to publish eagerly-anticipated COVID-19 trial results today

Cancer drug could help inhibit adenovirus infection

Cancer drug could help inhibit adenovirus infection

As winter comes other viruses will compete with SARS-CoV-2 for susceptible hosts

As winter comes other viruses will compete with SARS-CoV-2 for susceptible hosts

Cerebrospinal fluid autoantibodies target the brain in some COVID-19 patients

Cerebrospinal fluid autoantibodies target the brain in some COVID-19 patients

Human trials of potential COVID-19 vaccine commence in South Australia

Human trials of potential COVID-19 vaccine commence in South Australia

Oxford COVID-19 vaccine trials move to stage 3 human trials

Oxford COVID-19 vaccine trials move to stage 3 human trials